Reversing Resistance to Checkpoint Inhibitors and Targeted Therapy in Metastatic Melanoma.
Reversing Resistance to Checkpoint Inhibitors and Targeted Therapy in Metastatic Melanoma.
Clin Adv Hematol Oncol. 2020 Jul;18(7):408-410
Authors: Sznol M
PMID: 32903252 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research